Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penile Neoplasms | 7 | 2019 | 161 | 1.600 |
Why?
|
| Urinary Diversion | 7 | 2017 | 69 | 1.510 |
Why?
|
| Organ Sparing Treatments | 5 | 2019 | 277 | 1.500 |
Why?
|
| Urinary Reservoirs, Continent | 5 | 2012 | 31 | 1.420 |
Why?
|
| Adrenalectomy | 3 | 2019 | 188 | 1.200 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2019 | 489 | 0.990 |
Why?
|
| Urologic Surgical Procedures, Male | 5 | 2019 | 43 | 0.980 |
Why?
|
| Pheochromocytoma | 4 | 2008 | 281 | 0.830 |
Why?
|
| Penis | 4 | 2017 | 123 | 0.700 |
Why?
|
| Adrenal Glands | 2 | 2019 | 122 | 0.700 |
Why?
|
| Urinary Incontinence | 2 | 2010 | 149 | 0.670 |
Why?
|
| Urinary Bladder Diseases | 2 | 2017 | 45 | 0.660 |
Why?
|
| Kidney Neoplasms | 4 | 2019 | 3022 | 0.600 |
Why?
|
| Adrenal Gland Diseases | 1 | 2016 | 72 | 0.530 |
Why?
|
| Nephrectomy | 3 | 2019 | 779 | 0.530 |
Why?
|
| Testicular Neoplasms | 1 | 2019 | 529 | 0.520 |
Why?
|
| Printing, Three-Dimensional | 1 | 2016 | 129 | 0.490 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 143 | 0.470 |
Why?
|
| Vaginal Fistula | 1 | 2012 | 3 | 0.450 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2013 | 55 | 0.440 |
Why?
|
| Urinary Fistula | 1 | 2012 | 27 | 0.440 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 189 | 0.400 |
Why?
|
| Medical Illustration | 1 | 2011 | 34 | 0.390 |
Why?
|
| Vagina | 1 | 2012 | 317 | 0.370 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2010 | 37 | 0.350 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2017 | 2326 | 0.340 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2010 | 60 | 0.340 |
Why?
|
| Mesentery | 1 | 2007 | 72 | 0.300 |
Why?
|
| Colon, Transverse | 1 | 2007 | 8 | 0.300 |
Why?
|
| Ileostomy | 1 | 2007 | 46 | 0.300 |
Why?
|
| Ileum | 5 | 2011 | 165 | 0.290 |
Why?
|
| Scrotum | 1 | 2007 | 57 | 0.290 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2019 | 2341 | 0.280 |
Why?
|
| Urethra | 1 | 2006 | 144 | 0.280 |
Why?
|
| Counseling | 1 | 2008 | 381 | 0.270 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 5767 | 0.260 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 748 | 0.230 |
Why?
|
| Surgical Flaps | 1 | 2010 | 927 | 0.230 |
Why?
|
| Humans | 42 | 2019 | 261506 | 0.220 |
Why?
|
| Male | 29 | 2019 | 123000 | 0.220 |
Why?
|
| Androgens | 1 | 2005 | 511 | 0.210 |
Why?
|
| Vascular Neoplasms | 1 | 2003 | 114 | 0.210 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 190 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2005 | 321 | 0.190 |
Why?
|
| Quality of Life | 2 | 2017 | 4532 | 0.190 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 998 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 840 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 7551 | 0.170 |
Why?
|
| Urologic Surgical Procedures | 3 | 2010 | 93 | 0.170 |
Why?
|
| Life Expectancy | 1 | 2019 | 129 | 0.160 |
Why?
|
| Lithotripsy, Laser | 2 | 2008 | 8 | 0.160 |
Why?
|
| Ureteroscopy | 2 | 2008 | 46 | 0.160 |
Why?
|
| Ureteral Neoplasms | 1 | 2019 | 228 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2019 | 148 | 0.150 |
Why?
|
| Empyema | 1 | 2017 | 28 | 0.150 |
Why?
|
| Treatment Outcome | 12 | 2019 | 32848 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2019 | 500 | 0.130 |
Why?
|
| Urinary Bladder | 2 | 2017 | 575 | 0.130 |
Why?
|
| Follow-Up Studies | 8 | 2008 | 14889 | 0.110 |
Why?
|
| SEER Program | 2 | 2019 | 1000 | 0.110 |
Why?
|
| Mortality, Premature | 1 | 2012 | 11 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2019 | 962 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 3 | 2006 | 3981 | 0.100 |
Why?
|
| Urogenital Neoplasms | 1 | 2012 | 108 | 0.100 |
Why?
|
| Appendix | 1 | 2011 | 41 | 0.100 |
Why?
|
| Prostatectomy | 2 | 2019 | 962 | 0.100 |
Why?
|
| Urinary Bladder Fistula | 1 | 2010 | 13 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 5437 | 0.090 |
Why?
|
| Colon | 2 | 2004 | 670 | 0.090 |
Why?
|
| Kidney | 1 | 2019 | 2146 | 0.090 |
Why?
|
| Perineum | 1 | 2010 | 107 | 0.090 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 100 | 0.090 |
Why?
|
| Female | 14 | 2013 | 141928 | 0.090 |
Why?
|
| Child | 7 | 2010 | 29154 | 0.090 |
Why?
|
| Middle Aged | 16 | 2019 | 86204 | 0.080 |
Why?
|
| Adult | 13 | 2012 | 77950 | 0.080 |
Why?
|
| Angiomyolipoma | 1 | 2008 | 31 | 0.080 |
Why?
|
| Phenoxybenzamine | 1 | 2008 | 10 | 0.080 |
Why?
|
| Ureteral Calculi | 1 | 2008 | 16 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2008 | 16 | 0.080 |
Why?
|
| Ejaculation | 1 | 2007 | 24 | 0.080 |
Why?
|
| Tramadol | 1 | 2007 | 12 | 0.080 |
Why?
|
| Serotonin Agents | 1 | 2007 | 16 | 0.080 |
Why?
|
| Coitus | 1 | 2007 | 25 | 0.080 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 139 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2017 | 37905 | 0.070 |
Why?
|
| Tuberous Sclerosis | 1 | 2008 | 136 | 0.070 |
Why?
|
| Sus scrofa | 1 | 2007 | 169 | 0.070 |
Why?
|
| Neurosurgery | 1 | 2008 | 108 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2011 | 739 | 0.070 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2007 | 106 | 0.070 |
Why?
|
| Circumcision, Male | 1 | 2006 | 26 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2007 | 129 | 0.070 |
Why?
|
| Castration | 1 | 2005 | 122 | 0.070 |
Why?
|
| Cystoscopy | 1 | 2005 | 88 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 153 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8865 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 224 | 0.060 |
Why?
|
| Cystitis, Interstitial | 1 | 2004 | 4 | 0.060 |
Why?
|
| Aged | 11 | 2019 | 70117 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1363 | 0.060 |
Why?
|
| Cystitis | 1 | 2004 | 107 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 534 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 2139 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 630 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2002 | 69 | 0.050 |
Why?
|
| Intestinal Obstruction | 1 | 2004 | 202 | 0.050 |
Why?
|
| Survival Rate | 2 | 2008 | 12221 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2003 | 158 | 0.050 |
Why?
|
| Adolescent | 5 | 2008 | 31252 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 29902 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2007 | 691 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 915 | 0.050 |
Why?
|
| Stomach | 1 | 2004 | 387 | 0.050 |
Why?
|
| Testosterone | 1 | 2005 | 619 | 0.050 |
Why?
|
| Reoperation | 1 | 2004 | 1382 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 3639 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2017 | 10035 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 2992 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 384 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2004 | 2292 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2008 | 9244 | 0.040 |
Why?
|
| Age Factors | 1 | 2008 | 5377 | 0.040 |
Why?
|
| Hypertension | 1 | 2008 | 1503 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 13658 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 2403 | 0.040 |
Why?
|
| Anuria | 1 | 2017 | 14 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1945 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2008 | 16273 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 90 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7548 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2003 | 655 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 6150 | 0.030 |
Why?
|
| Urology | 1 | 2017 | 128 | 0.030 |
Why?
|
| Pain | 1 | 2004 | 1658 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2017 | 285 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2008 | 6869 | 0.030 |
Why?
|
| United States | 3 | 2019 | 15433 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3230 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 12926 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2007 | 8223 | 0.030 |
Why?
|
| Cystectomy | 1 | 2017 | 623 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2019 | 1824 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2005 | 5178 | 0.020 |
Why?
|
| Infant | 1 | 2006 | 13310 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 2218 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4298 | 0.020 |
Why?
|
| Patient Selection | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2004 | 5542 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 4988 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 192 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2010 | 319 | 0.020 |
Why?
|
| Holmium | 1 | 2007 | 23 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6207 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2008 | 181 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2007 | 409 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 460 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 202 | 0.020 |
Why?
|
| Anthropometry | 1 | 2005 | 269 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 1544 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 59536 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 3472 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 4971 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 4314 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 8873 | 0.010 |
Why?
|